Leading Pharmaceutical Companies Mid-day Trading with Mixed Results and also New Patent News Announced for Crown Marketing

Thu Feb 14, 2013 2:13pm EST

* Reuters is not responsible for the content in this press release.

Leading Pharmaceutical Companies Mid-day Trading with Mixed Results and also New Patent
News Announced for Crown Marketing

CORAL SPRINGS, Florida, February 14, 2013 /PRNewswire/ --

    FinancialNewsMedia.com reports on active HealthCare Companies experiencing mid-day
trading today with mixed results: Crown Marketing Pharmaceutical, Abbott Laboratories
(NYSE : ABT), Bristol-Myers Squibb Company (NYSE : BMY), GNC Holdings, Inc. (NYSE : GNC)
and Pfizer Inc. (NYSE : PFE).  

    Crown Marketing Pharmaceuticals was trading higher than normal volume by mid-day
trading over 1.5 Million Shares as the company issued news before the markets opened
today. To read the entire following press release details along with all the recent
Crown news, please go to http://www.marketwatch.com/investing/stock/cwnm. The press
release states Crown Marketing announced today that Patents for its Controlled Drug
Delivery Technology (CDDT) have been approved and registered in South Africa. This is
the Company's second major announcement regarding the approval of new Patents following
last week's news it had also secured Patents in Norway. Crown is continuing to secure
its worldwide patent rights as it pursues novel applications of its drug delivery
technology. For more details regarding Crown's CDDT applications, go to

    Abbott Laboratories (NYSE : ABT) engages in the discovery, development, manufacture,
and sale of health care products worldwide. It offers diagnostic systems and tests, such
as immunoassay and clinical chemistry systems; assays for screening and/or diagnosis for
drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and
infectious diseases. ABT was up $0.14 per share at mid-day trading on 4.5 Million shares
by 12:30pm EST.  

    Bristol-Myers Squibb Company (NYSE : BMY) announced this week it has entered into a
three-year collaboration agreement with Reckitt Benckiser Group plc (LSE : RBL) for
several of its over-the-counter medicines currently sold across Latin America, primarily
in Mexico and Brazil. BMY was up slightly in mid-day trading at $36.40 per share on 4.1
Million shares by 12:30pm EST.  

    GNC Holdings, Inc. (NYSE : GNC), a leading global specialty retailer of health and
wellness products, today reported its financial results for the quarter and year ended
December 31, 2012. Get the full report at
http://www.marketwatch.com/investing/stock/gnc. GNC was up over 8% in mid-day trading at
$39.14 per share on 6.7 Million shares by 12:45pm EST.  

    Pfizer Inc. (NYSE : PFE), a biopharmaceutical company, engages in the discovery,
development, manufacture, and sale of medicines for people and animals worldwide. It
primarily offers Celebrex, Chantix/Champix, Lipitor, Lyrica, Premarin, Pristiq, and
Viagra pharmaceutical products in the therapeutic and disease areas of Alzheimer's
disease, cardiovascular, erectile dysfunction, genitourinary, depressive disorder, pain,
respiratory, and smoking cessation. GNC was up slightly in mid-day trading at $27.07 per
share on 14.7 Million shares by 12:55pm EST.  

    FinancialNewsMedia.com [http://www.financialnewsmedia.com ] is a leading provider of
third party publishing & news dissemination services. If you would like more information
regarding our news coverage solutions, please visit http://www.financialnewsmedia.com
for more details.  

    DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news
dissemination service provider, which disseminates electronic information through
multiple online media channels. FNMG is NOT affiliated in any manner with any company
mentioned herein. FNMG and its affiliated companies are a news dissemination and
financial marketing solutions provider and are NOT a registered
broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to
sell or offer to buy any security. FNMG's market updates, news alerts and corporate
profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The
material in this release is intended to be strictly informational and is NEVER to be
construed or interpreted as research material. All readers are strongly urged to perform
research and due diligence on their own and consult a licensed financial professional
before considering any level of investing in stocks. The companies that are discussed in
this release may or may not have approved the statements made in this release. FNMG is
not liable for any investment decisions by its readers or subscribers. Investors are
cautioned that they may lose all or a portion of their investment when investing in


    This release contains "forward-looking statements" within the meaning of Section 27A
of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act
of 1934, as amended and such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans, results, or strategies
and are generally preceded by words such as "may", "future", "plan" or "planned", "will"
or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are
cautioned that such statements are subject to a multitude of risks and uncertainties
that could cause future circumstances, events, or results to differ materially from
those projected in the forward-looking statements, including the risks that actual
results may differ materially from those projected in the forward-looking statements as
a result of various factors, and other risks identified in a company's annual report on
Form 10-K or 10-KSB and other filings made by such company with the Securities and
Exchange Commission. You should consider these factors in evaluating the forward-looking
statements included herein, and not place undue reliance on such statements. The
forward-looking statements in this release are made as of the date hereof and FNMG
undertakes no obligation to update such statements.  

        Contact Information:
        Company: FN Media Group, LLC [http://www.financialnewsmedia.com ]
        Contact email: editor@financialnewsmedia.com
        U.S. Phone: +1-(954)345-0611
        URL: http://www.financialnewsmedia.com

FN Media Group LLC
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.